• Access To Medicines

Influencing and shaping our sector | BIA update: July - October 2020

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from July to October 2020.

BIA submission to the Comprehensive Spending Review 2020

Influencing and shaping our sector BIA update Q2 2020

The BioIndustry Association (BIA)’s ongoing engagement enables our members’ voices to be heard at the highest levels. This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from April to July 2020.

BIA submission to the 2020 Labour Health Commission

The BIA has submitted views to the 2020 Labour Party National Policy Forum commission on health and social care.

Life Sciences Recovery Roadmap

Influencing and shaping our sector | BIA update: January - April 2020

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from January to April 2020.

Influencing and shaping our sector | BIA update: October 2019 - January 2020

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from October 2019 to January 2020.

BIA response to the NHS Commercial Framework

BIA response to DIT consultation on UK-Japan trade

The BIA has responded to the Department for International Trade (DIT)’s consultation on UK-Japan trade.

BIA biotech manifesto 2019

The United Kingdom (UK) will have a general election on Thursday, 12 December. The UK BioIndustry Association (BIA) has launched a biotech manifesto with its recommendations on how political parties can support the innovative UK life sciences sector.